澳门太阳集团城网址8(中国)有限公司-百度百科

The 2017 Technical Committee Conference was held by National Anti-HIV Drugs Engineering and Technology Research Center in Shanghai Desano Pharmaceuticals Co., Ltd on 26th December, 2017. Experts attending the conference include Mr. Ding Kuiling, director of Shanghai institute of organic chemistry, Chinese academy of sciences, Mr. Lu Hongzhou, Party secretary of Shanghai public health clinical center, Mr. Song Gonghua, dean of College of pharmaceutics of East China University of Science and Technology, Mr. Zhang Wanbin, professor of Shanghai Jiaotong University, Mr. Lou Zhiyong, Yangtze river scholar and professor of Tsinghua University, Mr. Yu Zhixiang, Yangtze river scholar and distinguished professor of Peking University, Mr. Sun Hao, expert and professor of Thousand Talents Program of Tianjin University, Dr. Li Jinliang, director of National Anti-HIV Drugs Engineering and Technology Research Center of Shanghai Desano Pharmaceuticals Co., Ltd, Dr. Zhang Hua, vice director of National Anti-HIV Drugs Engineering and Technology Research Center of Shanghai Desano Pharmaceuticals Co., Ltd, Dr. Cai Zhigang, vice director of National Anti-HIV Drugs Engineering and Technology Research Center of Shanghai Desano Pharmaceuticals Co., Ltd, Mrs. An Xiaoxia, president of Shanghai Desano Biological Pharmaceutical Co., Ltd. In addition, Mr. Dong Shupei, vice director of bio-pharmaceutical department of Shanghai Science and Technology commission was also invited to attend this conference.

During the conference, Dr. Li Jinliang, director of technical committee reported about the performance of the National Anti-HIV Drugs Engineering and Technology Research Center in 2017 and introduced the work plan in 2018. Mrs. Zhao Nan and Mrs. Chen Yazi, who are the directors of engineering center, reported respectively on the technology of asymmetric synthesis and engineering of anti - HIV drugs, research and development of anti - HIV drugs, which got experts’ positive feedback and comments. Experts had an intense discussion on key generic technology of development direction of engineering center and technological development and provided pertinent suggestions. Mr. Dong Shupei, vice director of bio-pharmaceutical department of Shanghai Science and Technology commission was satisfied with the work of the center in 2017 and praise the center’s performance. He also suggested that engineering center should play a leading role in this industry, truly combine the center with experts and explore a better organization structure to cooperate on production-study-research to finally realize the Desano independent innovation.